BZ5-10052-24704
4 vaccinations
4 coded responses
41 check-ins
4 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 61-65
- ZIP prefix
- 662 / KS
- Registered
- 2021-03-03
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-03
Registered in v-safe
-
2021-03-03
Dose 1 — Pfizer-BioNTech
- 2021-03-03
- 2021-03-04
- 2021-03-05
- 2021-03-06
- 2021-03-07
- 2021-03-08
- 2021-03-09
- 2021-03-10
- 2021-03-17
-
2021-03-24
Dose 2 — Pfizer-BioNTech
- 2021-03-24
- 2021-03-25
- 2021-03-26
- 2021-03-27
- 2021-03-28
- 2021-03-29
- 2021-03-30
- 2021-03-31
- 2021-04-07
- 2021-04-16
- 2021-04-21
- 2021-04-28
- 2021-05-05
- 2021-06-25
- 2021-09-22
-
2021-09-24
Dose 3 — Pfizer-BioNTechCo-administered: Flu
- 2021-10-02
- 2021-10-08
- 2021-10-15
- 2021-10-22
- 2021-10-29
- 2021-11-05
-
2021-12-26
Survey response — 3 months, dose 3MedDRA: Cough, Nasopharyngitis, Rhinorrhoea — Feeling: GoodFree text: Had a very mild cold with a slight cough and a runny nose.MedDRA releases: 2024-11 · check-in free text available
- 2022-03-25
-
2022-04-04
Dose 4 — Pfizer-BioNTech
- 2022-04-14
- 2022-04-19
- 2022-04-25
- 2022-05-02
-
2022-05-11
Survey response — day 35, dose 4MedDRA: Headache, Oropharyngeal pain — Feeling: Fair · Be unable to work or attend schoolFree text: Sore throat and slight headacheMedDRA releases: 2024-11 · check-in free text available
-
2022-05-16
Survey response — day 42, dose 4MedDRA: Headache, Oropharyngeal pain, Respiratory tract congestion, Rhinorrhoea, SARS-CoV-2 test negative — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Runny nose, congestion, sore throat and headache but 2 rapid tests showed negative for COVIDMedDRA releases: 2024-11 · check-in free text available
- 2022-07-04
-
2022-10-03
Survey response — 6 months, dose 4MedDRA: Chills, Diarrhoea, Headache, Medical counselling, Patient isolation, Pyrexia, SARS-CoV-2 test positive — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professionalFree text: Symptoms: Chills, fever of 100.7, some diarrhea and headache only for 2 days (except diarrhea persisted 7 days after stopping Paxlovid). Took Paxlovid w/in 24 hrs of symptoms and testing Covid positive. Isolated 5 full days. No Covid recurrence. · Healthcare visit (other): Phone call w/Primary Care Dr.MedDRA releases: 2024-11 · check-in free text available
-
2022-10-03
Report sent to call center — 6 months, dose 4Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr1 call case(s)
-
2022-10-05
Call successfulNot applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
- 2023-04-04
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-03 | Pfizer-BioNTech | |
| 2 | 2021-03-24 | Pfizer-BioNTech | |
| 3 | 2021-09-24 | Pfizer-BioNTech | Flu |
| 4 | 2022-04-04 | Pfizer-BioNTech | No |
Call center
1 call center case
1 successful
Free text
Release 10 — 3 months, dose 3
Symptoms: Had a very mild cold with a slight cough and a runny nose.
Release 11 — day 35, dose 4
Symptoms: Sore throat and slight headache
Release 11 — day 42, dose 4
Symptoms: Runny nose, congestion, sore throat and headache but 2 rapid tests showed negative for COVID
Release 12 — 6 months, dose 4
Symptoms: Chills, fever of 100.7, some diarrhea and headache only for 2 days (except diarrhea persisted 7 days after stopping Paxlovid). Took Paxlovid w/in 24 hrs of symptoms and testing Covid positive. Isolated 5 full days. No Covid recurrence.
Healthcare visit (other): Phone call w/Primary Care Dr.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Medical counselling | · | · | ✓ |
| SD | Chills | · | · | ✓ |
| SD | Cough | · | · | ✓ |
| SD | Diarrhoea | · | · | ✓ |
| SD | Headache | · | · | ✓ |
| SD | Nasopharyngitis | · | · | ✓ |
| SD | Oropharyngeal pain | · | · | ✓ |
| SD | Patient isolation | · | · | ✓ |
| SD | Pyrexia | · | · | ✓ |
| SD | Respiratory tract congestion | · | · | ✓ |
| SD | Rhinorrhoea | · | · | ✓ |
| SD | SARS-CoV-2 test negative | · | · | ✓ |
| SD | SARS-CoV-2 test positive | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release